Practical Considerations to Help Patients with Type 2 Diabetes Start and Stay on Non-Insulin Injectable Therapies
Debbie Hinnen APN, BC-ADM, CDCES, FAAN joins The Huddle to share her expertise and experiences starting patients with type 2 diabetes on injectable, non-insulin therapies. We will cover topics like how to have a conversation with someone who may have concerns about starting a patient on an injectable, setting realistic expectations, storage and side effects.
Disclosures: Speaker/Consultant for Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk, Intuity
This podcast was developed in partnership with Eli Lilly and Company.
Resources:
Download a patient-focused tipsheet that complements the topics covered in this podcast. https://www.adces.org/docs/default-source/handouts/cvd/60-23_tipsheet-startstaynoninsulininjectable-9.pdf?sfvrsn=7f11759_5
1. https://pi.lilly.com/us/trulicity-uspi.pdf
2. https://www.bydureon.com/bydureon-bcise.html
3. https://www.novo-pi.com/victoza.pdf
4. https://www.novo-pi.com/ozempic.pdf
5. https://www.novo-pi.com/rybelsus.pdf
6. https://pi.lilly.com/us/mounjaro-uspi.pdf?s=pi
7. Triplitt & Solis-Herrera. The Diabetes Educator. 2015;41:S22
8. De Block et al., DOM. 2023;25:3
9. Frias et al., Lancet Diabetes Endocrinol. 2021;9:563
10. Jendle et al., Diabetes Metab Res Rev. 2016;32:776
11. El Sayed et al., Diabetes Care. 2023;46:S140
